633 related articles for article (PubMed ID: 33108380)
21. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
[No Abstract] [Full Text] [Related]
22. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
[TBL] [Abstract][Full Text] [Related]
23. Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies.
Nguyen NN; Mutnal MB; Gomez RR; Pham HN; Nguyen LT; Koss W; Rao A; Arroliga AC; Wang L; Wang D; Hua Y; Powell PR; Chen L; McCormack CC; Linz WJ; Mohammad AA
PLoS One; 2020; 15(10):e0240076. PubMed ID: 33022019
[TBL] [Abstract][Full Text] [Related]
24. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
25. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.
Serrano MM; Rodríguez DN; Palop NT; Arenas RO; Córdoba MM; Mochón MDO; Cardona CG
J Clin Virol; 2020 Aug; 129():104529. PubMed ID: 32659710
[TBL] [Abstract][Full Text] [Related]
26. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
Risch M; Weber M; Thiel S; Grossmann K; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Renz H; Kohler P; Vernazza P; Kahlert CR; Paprotny M; Risch L
Biomed Res Int; 2020; 2020():9878453. PubMed ID: 33224987
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans.
Martinaud C; Hejl C; Igert A; Bigaillon C; Bonnet C; Mérens A; Wolf A; Foissaud V; Leparc-Goffart I
J Clin Virol; 2020 Sep; 130():104571. PubMed ID: 32750664
[TBL] [Abstract][Full Text] [Related]
28. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
[No Abstract] [Full Text] [Related]
29. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
[TBL] [Abstract][Full Text] [Related]
30. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
[TBL] [Abstract][Full Text] [Related]
31. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
[TBL] [Abstract][Full Text] [Related]
32. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
Tuaillon E; Bolloré K; Pisoni A; Debiesse S; Renault C; Marie S; Groc S; Niels C; Pansu N; Dupuy AM; Morquin D; Foulongne V; Bourdin A; Le Moing V; Van de Perre P
J Infect; 2020 Aug; 81(2):e39-e45. PubMed ID: 32504735
[TBL] [Abstract][Full Text] [Related]
33. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
[TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of SARS-CoV-2 IgG assays in India.
Chaudhuri S; Thiruvengadam R; Chattopadhyay S; Mehdi F; Kshetrapal P; Shrivastava T; Desiraju BK; Batra G; Kang G; Bhatnagar S;
J Clin Virol; 2020 Oct; 131():104609. PubMed ID: 32866811
[TBL] [Abstract][Full Text] [Related]
35. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.
Patel R; Babady E; Theel ES; Storch GA; Pinsky BA; St George K; Smith TC; Bertuzzi S
mBio; 2020 Mar; 11(2):. PubMed ID: 32217609
[No Abstract] [Full Text] [Related]
36. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
[TBL] [Abstract][Full Text] [Related]
37. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.
Wang QJ; Yao YZ; Song JS; Wang Q; Xu LY; Bao ZJ; Mao DW; Zhou JH; Zhang ZE; Wang Y; Li YW; Wang HP; Li L; Pan HY; Zhang GQ; Li SB
BMC Infect Dis; 2020 Nov; 20(1):818. PubMed ID: 33167900
[TBL] [Abstract][Full Text] [Related]
38. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
[No Abstract] [Full Text] [Related]
39. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.
Johnson M; Wagstaffe HR; Gilmour KC; Mai AL; Lewis J; Hunt A; Sirr J; Bengt C; Grandjean L; Goldblatt D
J Clin Virol; 2020 Sep; 130():104572. PubMed ID: 32769024
[TBL] [Abstract][Full Text] [Related]
40. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
